The incumbent develops and evaluates mutually beneficial programs to define and deliver market access. Designs, develops and implements effective strategies for one or more of the following: pricing and reimbursement, health technology, evidence-based medicine review and/or health economic modeling. Communicates the unique attributes of therapeutic area drugs to external stakeholders to ensure the drug's value proposition will be recognized and maximize market uptake. Works collectively with payers, including HTA, reimbursement influencers and other decision makers to ensure continuous changing reimbursement systems remain fair to all involved parties.
He/she will support the company growth, through the best use of human capital and technical resources within the company and that activities are conducted in a manner consistent with:
1 Under general direction, responsible for identifying and getting optimal access to reimbursement channels for CSL Behring products in a designated territory.
2 Develops working relationships with key external channel customers in order to maintain understanding of current market conditions. Develops and maintains relationships with government, NGOs, advocacy groups, key opinion leaders and key wholesalers in order to generate reimbursement opportunities
3 Works cross functionally with marketing, medical and regulatory to develop value propositions for CSL products
4 Provides support for major tenders and updates management on reimbursement changes, healthcare policies, funding legislation, etc.
Oversee the regional/local tender process to ensure accreditation of CSL Behring in the platforms, and the inclusion of CSL Behring products into Regional/hospital Tenders
This role is based in Mechelen and requires to be 3 days a week onsite.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
